September 2025 - Page 2 of 2

TuesdaySep 02, 2025 10:00 am

QualityStocksNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Completes $5.3 Million Acquisition in Missouri

Strawberry Fields REIT (NYSE AMERICAN: STRW) announced it completed the acquisition of a facility in Poplar Bluff, Missouri, comprised of 108 skilled nursing beds and 16 assisted living beds, for $5.3 million. The facility was added to an existing master lease with an affiliate of Reliant Care Group L.L.C., increasing the Company’s annual rents by $530,000 with 3% annual escalators. This transaction marks Strawberry Fields’ 18th facility in Missouri. To view the full press release, visit https://ibn.fm/p9DO7 About Strawberry Fields REIT Strawberry Fields REIT, Inc., is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing…

TuesdaySep 02, 2025 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Secures New U.S. Contracts, Expands Presence into 11th State in Under a Year

SuperCom secures a second electronic monitoring (“EM”) contract in Alabama, strengthening its foothold in the state. The company has entered 11 new U.S. states since mid-2024, including Tennessee in July. Contracts follow a recurring revenue model, with agencies billed per daily active unit. Referrals from existing clients have driven repeat contracts, highlighting customer satisfaction. SuperCom’s PureSecurity(TM) Suite supports GPS monitoring, house arrest, and domestic violence prevention programs. Rising adoption of EM solutions reflects demand for alternatives to incarceration and data-driven public safety management. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, is accelerating its push…

TuesdaySep 02, 2025 9:20 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference

Clene (NASDAQ: CLNN) announced that management will present at the H.C. Wainwright 27th Annual Global Investment Conference and host one-on-one investor meetings. To view the full press release, visit https://ibn.fm/9cLjp About Clene Inc. Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. CNM-Au8(R)is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and…

TuesdaySep 02, 2025 9:00 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Expands Global Reach With Launch of SEGG Digital and SEGG Productions

SEGG Media (NASDAQ: SEGG, LTRYW), a sports, entertainment and gaming conglomerate that owns Sports.com, Concerts.com and Lottery.com, announced the launch of two new divisions, SEGG Digital and SEGG Productions, to accelerate international growth, audience engagement and monetization. SEGG Digital, led by Charlie Davis of Jet House and supported by influencer executive Ray Harris, will serve as the company’s marketing arm, deploying data-driven digital and social strategies to scale its flagship brands. SEGG Productions, led by Tamer Hassan, will focus on premium storytelling across music, lifestyle and entertainment, with its first major project, “SAS Unscripted,” hosted by Ant Middleton, already in…

TuesdaySep 02, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically significant reductions in suicidal ideation with IV ketamine versus placebo and comparators. Fast Track status makes NRX-100 eligible for Accelerated Approval and the Commissioner's National Priority Voucher program. NRx is preparing an expanded access policy and seeking meetings with FDA leadership to align on data submission. The U.S. suicidal depression market is estimated at more than $3 billion annually. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug…

Site Search

Company Search

Month: September 2025

QualityStocksNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Completes $5.3 Million Acquisition in Missouri

SuperCom Ltd. (NASDAQ: SPCB) Secures New U.S. Contracts, Expands Presence into 11th State in Under a Year

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Expands Global Reach With Launch of SEGG Digital and SEGG Productions

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

Market Basics

Newsletter Publishers

Public Companies